Skip to main content

7 Result(s)

within F. Chomy Remove this filter

and

  1. No Access

    Article

    Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?

    For patients with early stage non-small-cell lung cancer (NSCLC), thermal ablation (TA) has become in the least two decades an option of treatment used worldwide for patients with comorbidities who are not sur...

    J. Palussière, M. Cazayus, S. Cousin, M. Cabart, F. Chomy… in Current Oncology Reports (2021)

  2. Article

    Open Access

    Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer

    Brain metastases (BMs) are associated with poor prognosis in non-small cell lung cancer (NSCLC), but are only visible when large enough. Therapeutic decisions such as whole brain radiation therapy would benefi...

    M. Bilous, C. Serdjebi, A. Boyer, P. Tomasini, C. Pouypoudat… in Scientific Reports (2019)

    Download PDF (2352 KB) View Article

  3. Article

    Open Access

    Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial

    A prospective multicenter phase II trial to evaluate the survival outcomes of percutaneous radiofrequency ablation (RFA) for patients with stage IA non-small cell lung cancer (NSCLC), ineligible for surgery.

    J. Palussière, F. Chomy, M. Savina, F. Deschamps… in Journal of Cardiothoracic Surgery (2018)

    Download PDF (1203 KB) View Article

  4. No Access

    Article

    Huit fiches pratiques de conseil nutritionnel pour répondre aux besoins des patients âgés au cours de leur traitement de chimiothérapie: étude INOGAD

    The dietary counseling applied in the ongoing randomized control trial INOGAD was based on face to face interviewing and dietary cards during the successive cures of chemotherapy. The aim of this ancillary stu...

    J. Durrieu, C. Blanc-Bisson, M. Fonck, D. Béchade, Y. Becouarn, J. -F. Blanc… in Oncologie (2011)

  5. No Access

    Article

    Phase II combination of gefitinib and docetaxel for advanced or metastatic non-small cell lung cancer: clinical results and biological monitoring

    The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib and the cytotoxic agent docetaxel are both used for the second-line treatment of advanced non-small cell lung cancer (NSCLC). Thi...

    M. Gatineau, E. Dansin, F. Chomy, E. Lemarie, P. Nouyrigat, S. Oudard… in Targeted Oncology (2006)

  6. No Access

    Chapter

    Vertebral metastases of lung cancer

    In France, lung cancer is the principal cause of death by cancer in men and the fifth cause of death by cancer in women. It causes 21,500 deaths per year corresponding to approximately 16% of deaths by cancer ...

    F. Chomy in Vertebral metastases (2002)

  7. No Access

    Article

    A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma

    The aim of the protocol was to evaluate the side-effects induced by repeated tumour-infiltrating lymphocyte (TIL) infusions in patients with metastatic melanoma (MM). Patients were to receive four TIL infusion...

    A Ravaud, E Legrand, MM Delaunay, E Bussières, V Coulon… in British Journal of Cancer (1995)